|Articles|August 2, 2017
WIRB-Copernicus Group Acquires Patient Genesis’ ConsentNow eConsent
Advertisement
WIRB-Copernicus Group (WCG)-provider of regulatory and ethical review services (IRB) for human research-announced its acquisition of Patient Genesis' ConsentNow eConsent technology for healthare, pharmaceutical, and medical device companies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
2
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
3
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
4
Regulatory Uncertainty Emerges Across the Drug Development Lifecycle
5